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In this study the role of CXCL6 in diabetic nephropathy (DN) was investigated. It was
found to be overexpression in DN patients and DN rat model. And the expression of
fibrosis-related cytokines was consistent with the expression of CXCL6. High glucose
significantly increased the proliferation of rat renal fibroblasts NRK-49F cell and the
expression of CXCL6. Knockdown of CXCL6 ameliorated the pro-proliferation effect of
high glucose and decreased the expression of fibrosis-related cytokines, while CXCL6
overexpression exhibited the opposite phenomenon. Gene set enrichment analysis,
Western blot and ELISA showed that Janus kinase-signal transducer and activator
of transcription (JAK-STAT) and CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
signaling pathways were correlative with CXCL6. This data indicates that CXCL6 may
promote fibrosis-related factors to accelerate the development of DN renal interstitial
fibrosis by activating JAK/STAT3 signaling pathway. CXCL6 is promising to be a potential
novel therapeutic target and candidate biomarker for JAK/STAT3 signaling for the
treatment of DN.
Keywords: CXCL6, kidney, diabetics, fibrosis, pathway
INTRODUCTION
Diabetic nephropathy (DN) is a well-known micro-vascular complication of diabetes, and the
leading cause of ESRD (Gin et al., 2000). Over-deposition of the ECM in the renal interstitium
is the main cause of renal interstitial ﬁbrosis, which is the ﬁnal common pathway of the majority
of chronic progressive renal diseases, including DN (Strutz and Zeisberg, 2006). Fibroblasts are
Abbreviations: CCK-8, Counting Kit-8; CXCL6, C-X-C chemokine ligand 6; DMEM, Dulbecco’s modiﬁed Eagle medium;
DMSO, Dimethyl sulfoxide; DN, Diabetic Nephropathy; ECM, Extracellular matrix; ESRD, End-stage renal disease; FBS,
Fetal bovine serum; GSEA, Gene Set Enrichment Analysis; JAK, Janus kinase; MMP, Matrix metalloproteinase; STAT, Signal
transducer and activator of transcription; TGF-β1, Transforming Growth Factor β1; TNF-α, Tumor Necrosis Factor α.
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the major cells that produce ECM in the renal interstitium and
play an important role in the process of renal interstitial ﬁbrosis
(Grande and López-Novoa, 2009).
Many inﬂammatory factors are involved in the process of
renal interstitial ﬁbrosis in DN, such as chemokine, TGF-
β1, interleukin family, adhesion molecule, etc., which can
stimulate a series of inﬂammatory signaling pathways, resulting
in ECM thickening, interstitial ﬁbrosis, eventually triggering
renal dysfunction (Wada and Makino, 2013).
Chemokines are a class of chemotactic and inducible small
molecule peptides that are ubiquitous and play an important
role in acute and chronic inﬂammation (Wasmuth et al.,
2009). Among the chemokines, Soluble CXCL6 is an important
inﬂammatory cytokine that recruits inﬂammatory cells to the
site of inﬂammation by binding to the receptors CXCR1 and
CXCR2 (Sadik et al., 2011). In the cigarette-induced CXCL6-
deﬁcientmouse inﬂammationmodel, macrophage recruitment in
the lungs was signiﬁcantly reduced (Balamayooran et al., 2012).
CXCL6 is not only signiﬁcantly increased in inﬂammatory bowel
disease, but is also higher expressed in patients with periodontitis.
Immunohistochemistry has conﬁrmed that CXCL6 is mainly
distributed in gingival vascular endothelial cells (Kebschull et al.,
2009). Ionizing radiation can induce a signiﬁcant inﬂammatory
reaction in the skin, this can also promote the secretion of CXCL6
in fetal foreskin and adult human dermal ﬁbroblasts, and mast
cells mediate the secretion of CXCL6 (Müller andMeineke, 2011).
Microparticles, a small vesicle that accumulates in the synovial
ﬂuid of patients with rheumatoid arthritis, not only promotes
the secretion of inﬂammatory cytokines by synovial ﬁbroblasts
but also signiﬁcantly induces the secretion of the chemokine
CXCL6, thereby increasing the number of vascular endothelial
cell migration and thus promoting angiogenesis and aggravation
of joint inﬂammation (Reich et al., 2011). It has also been
reported that CXCL6 can also promote lung ﬁbrosis (Besnard
et al., 2013) and it is signiﬁcantly increased in patients with
idiopathic pulmonary ﬁbrosis.
Anti-CXL6 treatment of 2 weeks is reported to signiﬁcantly
decrease the levels of IL-1β, collagen andHuman Tissue Inhibitor
Of Matrix Metalloprotease-1 (TIMP-1) in Bleomycin-induced
lung inﬂammation and ﬁbrosis mouse model together with the
degree of lung inﬂammation and ﬁbrosis suggesting that CXCL6
plays an important role in the process of ﬁbrosis, however,
the mechanism of action is not clearly deﬁned (Besnard et al.,
2013). The aim of this study was to investigate the potential
functions and the underlying mechanism of CXCL6 in DN renal
interstitial ﬁbrosis.
MATERIALS AND METHODS
Patient Samples
All the tissue and plasma samples were obtained from The
Seventh People’s Hospital of Shanghai University of Traditional
Chinese Medicine between February 2015 and December 2015.
40 DN and 20 normal kidney tissue samples were harvested from
DN patients with kidney interstitial ﬁbrosis at the time of biopsy
or surgical resection. Plasma samples were collected from DN
patients (n = 40) with kidney interstitial ﬁbrosis and apparently
healthy subjects (n = 40) and the tissue and plasma samples were
stored at -80 C until used. The following data was recorded for
all participants: sex, age, and risk factors for DN (hyperlipidemia,
and glycosuria), showed in Supplementary Table S1.
This study was approved by the Medical Ethics Committee
of The Seventh People’s Hospital of Shanghai University of
Traditional Chinese Medicine and written informed consent was
obtained from all participants involved in this study.
Bioinformatics Analysis
CXCLs mRNA levels detected in human DN kidney samples
(n = 19) and healthy kidney tissue (n = 50) were obtained
from GEO DataSets (Asscess ID: GSE30122). Student’s t-test
was used to determine the statistical signiﬁcance of CXCLs
expression between human diabetic kidney samples and
healthy kidney tissue.
Gene Set Enrichment Analysis gene expression proﬁles
about ﬁbrosis was obtained from GEO DataSets (Asscess ID:
GSE28221) was analyzed by GSEA. GSEA was performed
using the GSEA software, Version 3.0, obtained from the
Broad Institute1. GSEA version 3.0 software was from the
Broad Institute at MIT. The nominal P-value and normalized
enrichment score (NES) was used to sort the pathways associated
with CXCL6-higher expression.
Animal Model Preparation
Male SD rats (160–200 g) were obtained from Shanghai
Sippr BK Laboratory Animals Ltd, (Shanghai, China).
After feeding high-sugar-fat diet for 8 weeks, the rats
were given a single intraperitoneal injection of 35 mg/kg
STZ. After 72 h, the rats with fasting and random blood
glucose reading of above 13.8 mmol/L, 16.7 mmol/L,
respectively, meanwhile glycosuria showing ++++ were
considered as diabetes. Four weeks after STZ injection, the
DN model rat was established when the uromicroprotein
exceeded 30 mg/day.
The animal experiments were carried out in accordance with
the guidelines issued by Medical Ethics Committee of The
Seventh People’s Hospital of Shanghai University of Traditional
Chinese Medicine.
Sample Collection
After the model was successfully established, urine specimen,
blood samples from rat heart, and renal tissues were collected
and kept for corresponding examination. The urinary albumin
concentration (U-Alb), urine albumin excretion (UAE),
serum creatinine (Scr), serum urea nitrogen (BUN), uric
acid (UA), and albumin (Alb) were measured by automatic
biochemical analyzer. The level of IL-6, TNF-α, TGF-β1,
CollagenI, CollagenIII, MMP2 and MMP9 in blood were
detected by enzyme linked immunosorbent assay (Elisa).
The expression of CXCL6, CXCR1, MMP2/9, CollagenI/III,
TGF-β1 in kidney tissues was determination by quantitative
real-time reverse transcription polymerase chain reaction
1http://software.broadinstitute.org/gsea/downloads.jsp
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(qRT-PCR) and Western blotting. General histology of renal
tissues was visualized by hematoxylin and eosin (H&E) and
Masson staining.
Cell Culture Experiments
A normal rat kidney ﬁbroblast cell line NRK-49F cells were
provided by the Shanghai Cell Bank, Chinese Academy of
Sciences (Shanghai, China) and cultured in DMEM, which
were supplemented with 10% FBS,100 units/mL penicillin and
100 µg/mL streptomycin at 37◦C and 5% CO2.
Cell Viability Analysis
Cells were seeded in 96-well plates at a density of 2000 cells
per well and incubated overnight. The cell proliferation was
quantitated using the Cell CCK-8; Dojindo Laboratories, Japan)
according to the manufacturer’s recommendations. Control cells
were treated with cultured media containing 0.15% (v/v) DMSO.
Lentivirus Transfection
The NRK-49F cells were seeded in 6-well plates, grown overnight
and transfected with CXCL6 shRNA viral or overexpression
lentivirus (both fromGeneChem, Shanghai, China) to investigate
the regulatory role of CXCL6. All of the transfections were
performed using the Lipofectamine 3000 reagent (Invitrogen R©;
Thermo Fisher Scientiﬁc, Inc.) according to the manufacturer’s
instructions. A blank vector lentivirus was used as a negative
control (NC). CXCL6 expression in cells following transfection
was conﬁrmed by western blot analysis and quantitative real-
time PCR.
Quantitative Real-Time PCR Analysis
(qRT-PCR)
Total RNA from the cells was extracted with TRIzol (Invitrogen,
Carlsbad, CA, United States) according to the manufacturer’s
protocol. The SYBR Green-based qRT-PCR (Thermo Fisher) was
performed to examine the relative CXCL6 and CXCR1 mRNA
level which was normalized with GAPDH. The CXCL6 primers
were: Primer F 5′-CTTAGCTCCAAGAATTAACC-3′; Primer R
5′- GGTCAAGACAAACATTATCC-3′. CXCR1 primers were:
Primer F 5′- TCTTCCGCCAGGCATATAAAC-3′; Primer R
5′-TAGCAGACCAGCATGATGAAC-3′. The GAPDH primers
were: Primer F 5′- CACCCACTCCTCCACCTTTG-3′; Primer R
5′- CCACCACCCTGTTGCTGTAG -3′.
Western Blots
The bands were determined by western blotting using
the enhanced chemiluminescent substrate (ECL, BioRad,
FIGURE 1 | Expression of CXCL6 was upregulated in DN patients. (A) CXCL mRNA expression file of 19 human DN kidney samples and 50 healthy kidney tissue
were performed based on GEO DataSets (Asscess ID: GSE30122). (B) The expression level of CXCL6 in human DN kidney samples (n = 19) and healthy kidney
tissue (n = 50) (∗∗∗P < 0.001). (C) The Serum levels of CXCL6 in normal (n = 40) and DN patients (n = 40) with kidney interstitial fibrosis were determined using Elisa.
(D) CXCL6 mRNA levels detected in 20 human DN kidney samples and 40 healthy kidney tissues using qRT-PCR. ∗∗∗P < 0.001.
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FIGURE 2 | Fibrosis related cytokines in DN rat model. (A) H&E and Masson staining of renal tissues. (a) H&E staining of renal tissues in control group (b) H&E
staining of renal tissues model group (c) masson staining of renal tissues in control group (d) masson staining of renal tissues model group (B) the levels of several
fibrosis related cytokines in peripheral blood were measured by Elisa. (C) Relative mRNA expressions of several fibrosis related cytokines were determined by
qRT-PCR (D) the protein levels of several fibrosis related cytokines were examined by Western blotting. ∗∗∗p < 0.001 vs. model group.
Richmond, CA, United States) in accordance with the
manufacturer’s instruction.
Cytokine Detection
The ﬁbrosis-related cytokines IL-6, TNF-α, TGF-β1, CollagenI,
CollagenIII, MMP2 and MMP9 were detected in cell culture
supernatants and plasma samples. The following were used to
measure the concentrations of cytokines: The Rat IL-6 ELISA
kit, the Rat TNF-αELISA kit, the Rat TGF-β1 ELISA Kit, the
Rat CollagenIII ELISA kit, the Rat Collagen ELISA kit, the Rat
MMP2 ELISA kit, and the RatMMP9 ELISA kit (Xinyu Biological
Technology, Shanghai, China).
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Histology
The tissue samples were ﬁxed with 4% paraformaldehyde,
dehydration and embedded in paraﬃn. General histology was
visualized by hematoxylin and eosin (H&E) and Masson
staining. The stained tissues were observed under an optical
microscope, the renal ﬁbrosis and collage deposition were
estimated, respectively.
Statistical Analysis
The data are presented as the mean± SD, and all the experiments
were performance three times independently. Unpaired two-
tailed student’s t-test was used to compare the diﬀerence between
TABLE 1 | The detail data of biochemical indicators in each group (Mean ± SD,
n = 6).
Indicator NC DN rat model
Blood glucose (mM) 3.98 ± 0.21 16.42 ± 0.76∗∗∗
Scr (µmol/L) 129.21 ± 9.04 457.75 ± 16.06∗∗∗
BUN (mmol/L) 4.44 ± 0.35 10.80 ± 0.30∗∗∗
UA (µmol/L) 101.09 ± 3.59 203 ± 5.19∗∗∗
Alb(g/L) 39.5 ± 0.98 23.37 ± 0.76∗∗∗
U-Alb(µg/ml) 350.83 ± 44.24 1036.37 ± 25.94∗∗∗
UAE(mg/L·h) 14.62 ± 1.23 43.18 ± 1.18∗∗∗
∗∗∗compared with control: P < 0.001.
the two groups. The one-way analysis of variance (ANOVA) test
with Dunnet t was performed for comparisons in the multiple
groups and P < 0.05 was considered statistically signiﬁcant.
RESULTS
CXCL6 Is Overexpression in DN
In order to deﬁne the CXCLs expression patterns in DN, the
CXCLs (CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL8,
CXCL9, CXCL10, CXCL11, CXCL12, CXCL13, and CXCL14)
mRNA levels in GEO DataSets (Asscess ID: GSE30122)
were analyzed (Figure 1A). It was found that CXCL6 (3.08
fold, P < 0.001) was signiﬁcantly higher in DN human
kidney than in control (Figure 1B). Then Elisa and qRT-
PCR were used to conﬁrm the transcript of CXCL6 and it
was found that CXCL6 was higher in plasma (Figure 1C)
and kidney tissue (Figure 1D) of DN than in the control
samples (P < 0.001).
The DN rat model was established by high-sugar-fat diet
combined with a single intraperitoneal injection of streptozocin
(STZ). As shown in Table 1, the level of blood glucose, Scr, BUN,
UA, U-Alb, and UAE in the DN model group was drastically
increased and Alb was decreased compared with the control
group. Histology staining with H&E and Masson revealed typical
damage and severe collagen ﬁbrosis of kidney tissues in the DN
model group (Figure 2A). The results of qRT-PCR and Western
FIGURE 3 | Effect of glucose on the expression of CXCL6 in NRK-49F cells. Cells were cultured with several concentrations of glucose (0, 5, 10, 15, 25, 50 mM) for
12 h, 24 h, and 48 h. CXCL6 expression level in NRK-49F was analyzed by qRT-PCR (A) and WB (B). CXCL6 concentration in NRK-49F cell culture supernatants
was measured by Elisa (C). ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001.
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blot were showed in Figures 2C,D. The expression of CXCL6
and its receptor CXCR1 of kidney tissues in the DN model
group was signiﬁcantly higher in DN rat kidney tissue than in
the control group.
Fibrosis-Related Cytokines Is High
Expression in DN Rat Model
The level of ﬁbrosis related cytokines (IL-6, TNF-α, TGF-
β1, CollagenI/III, MMP2/9) in serum and the expression
of CollagenI/III, MMP2/9 in kidney tissues were detected
by Elisa, qRT-PCR and Western blot. As displayed in
Figure 2B, the levels of IL-6, TNF-α, TGF-β1, CollagenI,
CollagenIII, MMP2 and MMP9 were increased signiﬁcantly
when compared with the control group. And the expression of
CollagenI/III, MMP2/9 of kidney tissues were signiﬁcantly
upregulated at both mRNA and protein levels in the
DN model group of animals compared with the control
group (Figures 2C,D).
Glucose Increases the Expression of
CXCL6 in NRK-49F Cells
Then eﬀects of glucose on the expression of CXCL6 and its
receptor CXCR1 in rat renal interstitial ﬁbroblasts NRK-49F cells
were detected by qRT-PCR and Western blotting after treatment
with 5 mM, 10 mM, 15 mM, 25 mM, and 50 mM glucose, and
further detected by ELISA. The results showed that 10 mM,
15 mM, 25 mM, 50 mM glucose signiﬁcantly increased the
expression of CXCL6 and CXCR1 both at mRNA (Figure 3A)
and protein level (Figure 3C) in a concentration-dependent
manner, furthermore the expression of CXCL6 increased with the
treatment time of glucose (Figure 3B).
CXCL6 Promoted the Proliferation of
NRK-49F Cell
To further investigate the function of CXCL6 in high glucose-
induced NRK-49F cells, lentivirus were transfected into high
glucose (25 mM) induced NRK-49F, then the expression of
FIGURE 4 | Effect of CXCL6 on the proliferation of high glucose-induced NRK-49F. The efficiency of CXCL6 shRNA viral or overexpression lentivirus in silencing or
over-expressing CXCL6 in NRK-49F cells was determined by qRT-PCR (A) and WB (B). Following this, cck8 assays were performed to evaluate high
glucose-induced NRK-49F cell viability when CXCL6 was either knocked down (C) or over-expressed (D). ∗∗P < 0.01, ∗∗∗P < 0.001.
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FIGURE 5 | Effects of CXCL6 on fibrosis related factors in high glucose-induced NRK-49F. The levels of IL-6, TGF-α/TGF-β1, Collagen I/III and MMP2/MMP9 in
CXCL6 knocked down (A) and CXCL6 overexpressed (B) NRK-49F cell culture supernatants were determined by Elisa assay. ∗∗∗P < 0.001.
CXCR1 and CXCL6 were measured by RT-PCR and Western
blotting. As shown in Figures 4A,B, compared with control,
CXCL6 gene interference and over-expression resulted in a
signiﬁcant downregulation or upregulation of CXCL6 both at the
mRNA and protein levels.
Then the eﬀects of CXCL6 on high glucose-induced
NRK-49F cells viability were investigated by CCK-8
assay. As shown in Figure 4C, high glucose (25 mM)
increased the proliferation of NRK-49F cells strikingly.
However, the proliferation of NRK-49F cell induced by
high glucose was decreased markedly by knockdown
CXCL6. Overexpression of CXCL6 signiﬁcantly promoted
the proliferation of high glucose (25 mM) induced NRK-
49F cell and the addition of 30 uM JAK inhibitor AG490
obviously reduced the proliferation of NRK-49F induced by
CXCL6 overexpression (Figure 4D).
CXCL6-Associated Signaling Pathways
To probe the CXCL6-associated pathways in ﬁbrosis, GSEA
were performed using RNA-sequencing data from the GEO
DataSets (Asscess ID: GSE28221). JAK-STAT and CYTOKINE
_CYTOKINE _RECEPTOR _INTERACTION signaling
pathways were found to be strongly associated with CXCL6
expression (Figure 6A).
CXCL6 Increased the Expression of
Fibrosis-Related Cytokines in NRK-49F
Cells
The expression of IL-6, TNF-α, TGF-β1, CollagenI, CollageIII,
MMP2 and MMP9 in the cell supernatant was detected by
ELISA. As shown in Figure 5, the expression of these cytokines
was increased by high glucose concentration (25 mM) and
overexpression of CXCL6 showed the same eﬀect. On the
contrary, the expression of these cytokines was decreased sharply
by knockdown of CXCL6and 30 uM JAK inhibitor AG490
signiﬁcantly decreased CXCL6 overexpression-induced ﬁbrosis-
related cytokines expression. The expression of CollagenI/III,
MMP2/9, PCNA, and p-STAT3 intracellular were evaluated
by western blot. In Figures 6B,C, the results were consistent
with that from ELISA. 25 mM glucose and overexpression of
CXCL6 markedly promoted the expression of CollagenI/III,
MMP2/9, PCNA, and p-STAT3. Knockdown of CXCL6 and
treatment with 30 uM JAK inhibitor AG490 drastically
decreased their expression. The expression of STAT3 was
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FIGURE 6 | CXCL6-associated pathways in DN. (A) GSEA was performed using GEO DataSets (Asscess ID: GSE28221). The JAK/STAT and CYTOKINE
_CYTOKINE _RECEPTOR _INTERACTION pathways were identified with the strongest association with CXCL6 expression. (B,C) Key moderators were determined
by western blotting. Data were based on at least three independent experiments, and shown as mean ± SD. ∗∗∗P < 0.001.
also measured, and no signiﬁcant change was observed
in all the groups.
DISCUSSION
CXCL6 is a member of the chemokine family and plays a crucial
role in experimental bleomycin-induced pulmonary ﬁbrosis
(Besnard et al., 2013). However, previous studies did not clarify
the roles of CXCL6 in DN renal interstitial ﬁbrosis. In this study,
we revealed the overexpression of CXCL6 in DN and explored the
underlying mechanism of CXCL6 in DN renal interstitial ﬁbrosis.
There is emerging evidence that renal interstitial ﬁbrosis
is the most important pathologic feature of DN (He et al.,
2016). Excessive deposition of ECM is the main reason of
renal interstitial ﬁbrosis (Picard et al., 2008) and it is widely
believed that renal interstitial ﬁbroblasts are the main cells
which play an important role in renal interstitial ﬁbrosis due to
producing excessive ECM (Faulkner et al., 2005). High glucose
concentration, a distinctive risk factor in diabetes, is a potential
stimulus for the proliferation, diﬀerentiation, and survival of
certain types of cells (Lee and Han, 2010; Yuan et al., 2011;
Le et al., 2012). Hence we explored the impacts of glucose
on renal interstitial ﬁbroblasts NRK-49F cell proliferation. The
results from cck8 assay indicated that (10, 15, 25, 50 mM)
glucose signiﬁcantly promoted the proliferation of NRK-49F
cells. Meanwhile, CXCL6 and CXCR1 expression were also
dramatically induced by high glucose in a dose-dependent
manner, demonstrating that CXCL6 may be a key factor in high
glucose-induced renal ﬁbrosis.
Then we examined the functions of CXCL6 in renal
interstitial ﬁbrosis. CXCL6 shRNA lentivirus was transfected
into NRK-49F and we conﬁrmed that CXCL6 shRNA viral
transfection markedly reduced CXCL6 expression at protein
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levels and partially attenuated the pro-proliferation eﬀects of
high glucose. On the contrary, ectopic expression of CXCL6
in NRK-49F signiﬁcantly promoted the proliferation of NRK-
49F. These data suggest that increasing the expression of
CXCL6 contributes to high glucose-induced renal ﬁbroblasts
proliferation and activation.
In addition to cellular phenotype, we explored the molecular
mechanism by which CXCL6 functions as an pro-ﬁbrotic factor
in DN. Overexpression of CXCL6 remarkably up-regulated
the expression of pro-inﬂammatory cytokine (such as TNF-
α and IL-6) and pro-ﬁbrotic markers (such as TGF-β, and
collagen). Moreover, The JAK/STAT signaling pathway has
previously been shown to implicate in the pathophysiology of
ﬁbrotic renal disease (Matsui and Meldrum, 2012; Matsui et al.,
2017). Increasing the activity of genes involved in JAK/STAT
signaling pathway may mediate renal ﬁbrosis. In the present
study, GSEA data indicated that higher CXCL6 expression
was positively correlated with JAK/STAT pathways in ﬁbrosis
(Figure 5A). The expression of JAK/STAT and CYTOKINE
_CYTOKINE _RECEPTOR _INTERACTION pathway related
factors was signiﬁcantly suppressed by CXCL6 knockdown,
while overexpression of CXCL6 in NRK-49F cells caused an
inverse eﬀect. With the addition of JAK inhibitor AG490,
the proliferation of NRK-49F and the expression of these
related factors induced by overexpression CXCL6 were inhibited
signiﬁcantly. These data suggest the roles of CXCL6 on
JAK/STAT3, and may account for renal ﬁbroblasts proliferation
and renal interstitial ﬁbrosis.
Approximately 30–40% of patients with diabetes develop
nephropathy (Tesch, 2017) and the exact pathogenesis of
DN is complex. Pathogenetic factors include hyperglycaemia,
increased intraglomerular, the immune system, and systemic
blood pressure, etc., Moreover, several cytokines and growth
factors, which have complex mutual interactions, have been
identiﬁed and may cause damaging eﬀects on the kidney (Kim
and Park, 2017). Renal response on these noxious eﬀects further
enhances renal damage. Although a number of therapeutic
interventions have been shown to postpone the development or
slow down the progression of DN, the proportion of ESRD due
to DN remains high (Jin, 2015). Therefore, future interventions
of other potential pathogenic factors were needed. Moreover,
the use of representative animal models to deﬁned clinical trial
inclusion criteria may help to identify appropriate DN therapies.
CONCLUSION
In conclusion, this study found that CXCL6 is overexpression
in DN patients and the DN rat model, and the expression of
ﬁbrosis-related cytokines was consistent with the expression of
CXCL6. The results of in vitro experiment showed that high
glucose concentration promotes renal ﬁbroblasts proliferation
and CXCL6 expression in NRK-49F. Knockdown of CXCL6
signiﬁcantly inhibited the proliferation of NRK-49F and
decreased the expression of pro-inﬂammatory and pro-ﬁbrotic
cytokines, while overexpression of CXCL6 exhibited the opposite
phenomenon. In addition JAK inhibitor AG490 showed the same
eﬀect as knockdown of CXCL6 and it is likely that CXCL6 may
promote ﬁbrosis-related factors to accelerate the development of
DN renal interstitial ﬁbrosis by activating JAK/STAT3 signaling
pathway. These ﬁndings not only broaden our understanding of
the pathogenesis of renal DN but also provide a new attractive
strategy in treating this disease. Due to the complexity and
heterogeneity of the DN, further investigations of the molecular
mechanisms of CXCL6 in DN are required to verify the
function of CXCL6 in DN.
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